Extracellular matrix protein expression in cerebrospinal fluid from patients with tropical spastic paraparesis associated with HTLV‐I and Creutzfeldt‐Jakob disease

REFERENCES

• Gessain A, Bann F, Vernant J, Gout O, Maurs L, Calender A, de The G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985; 2: 407–10.
   Google Scholar
• Cartier L, Mora C, Araya F, Castillo JL, Verdugo R. HTLV-I positive spastic paraparesis in a temperate zone. Lancet 1989; 1: 556–60.
   Google Scholar
• Cartier L, Cea JG, Vergara C, Araya F, Born P. Clinical and neuropathological study of six patients with spastic paraparesis associated with HTLV-I. An axomielynic degeneration of the central nervous system. J Neuropathol Exp Neurol 1997; 56: 403— 13.
   Google Scholar
• Lin HC, Dezzutti CS, Lal RB, Rabson AB. Activation of human T-cell leukemia virus type 1 tax gene expression in chronically infected cells. J Virol 1998; 72: 6264–70.
   Google Scholar
• Masters CL, Harris JO, Gajdusek DC, Gibbs CI Jr, Bernoulli C, Asher DM. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol 1979; 5: 177–88.
   Google Scholar
• Gálvez S, Cartier L. Clinical analysis of a series of 69 definitive cases of Creutzfeldt-Jakob occurring in Chile between 1960-1985. Rev Med Chile 1987; 115: 1148–54.
   Google Scholar
• Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95: 13363–83.
   PubMed Web of Science ®Google Scholar
• Brown DR. Prion and prejudice: normal protein and the synapse. Trends Neurosci 2001; 24: 85–90.
   Google Scholar
• Umehara F, Okada YO, Fujimoto N, Abe M, Izumo S, Osame M. Expression of matrix metalloproteinases and tissue inhibitors of metallo-proteinases in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol 1998; 57: 839–49.
   PubMed Web of Science ®Google Scholar
• Giraudon P, Szymocha R, Buart S, Bernard A, Cartier L, Belin MF, Akaoka HT. T-lymphocytes activated by persistent viral infection differentially modify the expression of metalloproteinases and their endogeneous inhibitors, TIMPs, in human astrocytes: relevance to HTLV-I-induced neuro-logical disease. J Immunol 2000; 164: 2718–27.
   Google Scholar
• Lezin A, Buart S, Smadja D, Akaoka H, Bourdonné O, Perret-Liaudet A, Cesaire R, Belin MF, Giraudon P. Tissue inhibitor of metalloproteinase 3, matrix metalloproteinase 9, and neopterin in the cerebrospinal fluid: prefer-ential presence in HTLV type I-infected neurologic patients versus healthy virus carriers. Aids Res Human Retrovir 2000; 16: 965–72.
   Google Scholar
• Kettlun AM, Cartier L, Garcia L, Collados L, Vásquez F, Ramirez E, Valenzuela MA. MMPs and MMPs expression in CSF from patients with TSP/HAM. Life Sci 2003; 72: 2863–76.
   Google Scholar
• Kettlun AM, Collados L, Garcia L, Cartier LA, Mosnaim AD, Wolf ME, Valenzuela MA. Matrix metalloproteinases profile in patients with Creutzfeldt-Jakob disease. Int J Clin Pract 2003; 57: 467–78.
   Google Scholar
• Venstrom KA, Reichardt LF. Extracellular matrix 2: role of extracellular matrix molecules and their receptors in the nervous system. FASEB J 1993; 7: 996–1003.
   PubMed Web of Science ®Google Scholar
• Sternlicht MD, Werb Z. How matrix metallopro-teinases regulate cell behavior. Annu Rev Cell Dev Biol 2001; 17: 463–516.
   PubMed Web of Science ®Google Scholar
• Dow KE, Wang W. Cell biology of astrocyte proteoglycans. Cell Mol Life Sci 1998; 54: 567–81.
   PubMed Web of Science ®Google Scholar
• Sobel RA. The extracellular matrix in multiple sclerosis: an update. Braz J Med Biol Res 2001; 34: 603–9.
   Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265–75.
   PubMed Web of Science ®Google Scholar
• Galeno H, Ramirez E, Mora M, Ojeda M, Cartier L. Anti-HTLV-I antibody titers in seropositive infected individuals. Rev Med Chile 1994; 122: 1004–7.
   Google Scholar
• Ramirez E, Cartier L, Rios M, Fernández J. Defective human T-cell lymphotropic virus type I (HTLV-I) provirus in 10 Chilean seronegative patients with tropical spastic paraparesis or HTLV-I-associated myelopathy. J Clin Microbiol 1998; 36: 1811–3.
   Google Scholar
• Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci. 2001; 24: 519–50.
   PubMed Web of Science ®Google Scholar
• Wiltfang J, Otto M, Baxter HC, Bodemer M, Steinacker P, Bahn E, Zerr I, Kornhuber J, Kretzschmar HA, Poser S, Ruther E, Aitken A. Isoform pattern of 14-3-3 proteins in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J Neurochem 1999; 73: 2485–90.
   PubMed Web of Science ®Google Scholar
• Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–5.
   PubMed Web of Science ®Google Scholar
• Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applica-tions. Proc Natl Acad Sci USA 1979; 76: 4350–4.
   Google Scholar
• Letourneau PC, Condic ML, Snow DM. Inter-actions of developing neurons with the extracell-ular matrix. J Neurosci 1994; 14: 915–28.
   Google Scholar
• Stichel CC, Milner HW. Experimental strategies to promote axonal regeneration after traumatic central nervous system injury. Prog Neurobiol 1998; 56: 119–48.
   Google Scholar
• Eitzen U, Egensperger R, Kosel S, Grasbon-Frodl EM, Imai Y, Bisek K, Kohsaka S, Mehracin P, Graeber MB. Microglia and the development of spongiform change in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol 1998; 57: 246–56.
   Google Scholar
• VanSaun M, Werle MJ. Matrix metalloproteinase-3 removes agrin from synaptic basal lamina. J Neurobiol 2000; 43: 140–9.
   PubMedGoogle Scholar
• Luckenbill-Edds L. Laminin and the mechanism of neuronal outgrowth. Brain Res Rev 1997; 23: 1–27.
   PubMedGoogle Scholar
• Tang D, Goldberg DJ. Bundling of microtubules in the growth cone induced by laminin. Mol Cell Neurosci 2000; 5: 303–13.
   Google Scholar
• Iozzo RV. Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 1998; 67: 609–32.
   PubMed Web of Science ®Google Scholar
• Buée L, Hof PR, Roberts DD, Delacourte A, Morrison JH, Fillit HM. Immunohistochemical identification of thrombospondin in normal human brain and in Alzheimer's disease. Am J Pathol 1992; 141: 783–8.
   Google Scholar
• Rusnati M, Taraboletti G, Urbinati C, Tulipano G, Giuliani R, Molinari-Tosatti MP, Sennino B, Giacca M, Tyagi M, Albini A, Noonan D, Giavazzi R, Presta M. Thrombospondin-1/HIV-1 Tat protein interaction: modulation of the bio-logical activity of extracellular Tat. FASEB J 2000; 14: 1917–30.
   Google Scholar
• Qian X, Wang TN, Rothman VL, Nicosia RF, Tuszynski GP. Thrombospondin-1 modulates angiogenesis in vitro by up-regulation of matrix metalloproteinase-9 in endothelial cells. Exp Cell Res 1997; 235: 403–12.
   Google Scholar